✦ LIBER ✦

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

✍ Scribed by Freedman, Mark S.; Stefano, Nicola; Barkhof, Frederik; Polman, Chris H.; Comi, Giancarlo; Uitdehaag, Bernard M. J.; Casset-Semanaz, Florence; Hennessy, Brian; Lehr, Lorenz; Stubinski, Bettina; Jack, Dominic L.; Kappos, Ludwig

Book ID: 121573888
Publisher: Springer
Year: 2014
Tongue: English
Weight: 397 KB
Volume: 261
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-013-7222-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of interferon β-1a on optic n

The effect of interferon β-1a on optic neuritis relapse in patients with multiple sclerosis

✍ Yan-Ming Chen; Chih-Chao Yang; I-Hua Wang; Fung-Rong Hu; Jieh-Ren Jou 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 141 KB

Randomised double-blind placebo-controll

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

✍ George C Ebers 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 97 KB

Long-Term Cost Effectiveness of Interfer

Long-Term Cost Effectiveness of Interferon-β-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis

✍ Claude Lepen, Patricia Coyle, Timothy Vollmer, Lance Blumhardtf, Hervé Lilliu, D 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 145 KB

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp

The Neurodegenerative Process in Multipl

The Neurodegenerative Process in Multiple Sclerosis and the Possible Neuroprotective Effect of Treatment with β-Interferon 1a (Avonex)

✍ Davydovskaya, M. V.; Boiko, A. N.; Podoprigora, A. E.; Pronin, I. N.; Kornienko, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 205 KB

Effect of prior treatment status and rea

Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)

✍ Khatri, B.O.; Pelletier, J.; Kappos, L.; Hartung, H.-P.; Comi, G.; Barkhof, F.; 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 600 KB